- Home
- MOS vs RGEN Comparison
MOS vs RGEN Comparison
Compare MOS & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOS
- RGEN
- Stock Information
- Founded
- MOS 1987
- RGEN 1981
- Country
- MOS United States
- RGEN United States
- Employees
- MOS 13765
- RGEN N/A
- Industry
- MOS Agricultural Chemicals
- RGEN Medical/Dental Instruments
- Sector
- MOS Industrials
- RGEN Health Care
- Exchange
- MOS Nasdaq
- RGEN Nasdaq
- Market Cap
- MOS 11.2B
- RGEN 8.0B
- IPO Year
- MOS 2004
- RGEN N/A
- Fundamental
- Price
- MOS $37.26
- RGEN $127.47
- Analyst Decision
- MOS Buy
- RGEN Buy
- Analyst Count
- MOS 12
- RGEN 12
- Target Price
- MOS $34.83
- RGEN $170.40
- AVG Volume (30 Days)
- MOS 6.2M
- RGEN 694.0K
- Earning Date
- MOS 08-05-2025
- RGEN 07-29-2025
- Dividend Yield
- MOS 2.36%
- RGEN N/A
- EPS Growth
- MOS N/A
- RGEN N/A
- EPS
- MOS 1.15
- RGEN N/A
- Revenue
- MOS $11,064,300,000.00
- RGEN $650,429,000.00
- Revenue This Year
- MOS $17.03
- RGEN $13.93
- Revenue Next Year
- MOS N/A
- RGEN $14.35
- P/E Ratio
- MOS $32.28
- RGEN N/A
- Revenue Growth
- MOS N/A
- RGEN 4.88
- 52 Week Low
- MOS $22.36
- RGEN $102.97
- 52 Week High
- MOS $38.06
- RGEN $182.52
- Technical
- Relative Strength Index (RSI)
- MOS 69.11
- RGEN 54.11
- Support Level
- MOS $34.88
- RGEN $121.44
- Resistance Level
- MOS $38.06
- RGEN $131.43
- Average True Range (ATR)
- MOS 0.90
- RGEN 4.47
- MACD
- MOS 0.07
- RGEN 0.61
- Stochastic Oscillator
- MOS 90.23
- RGEN 74.57
About MOS Mosaic Company (The)
Mosaic is one of the largest phosphate and potash producers in the world. The company's assets include phosphate rock mines in Florida, Brazil, and Peru and potash mines in Saskatchewan, New Mexico, and Brazil. Mosaic also runs a large fertilizer distribution operation in Brazil through its Mosaic Fertilizantes business.
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.